🔸Demuestran que un tratamiento innovador reduce la mortalidad por neumonía asociada en lactantes con VIH www.rtve.es/n/16659345/
14.07.2025 21:30 — 👍 14 🔁 4 💬 0 📌 0
Un ensayo clínico del 12 de Octubre demuestra un tratamiento que reduce la mortalidad por neumonía en lactantes con VIH
Un ensayo clínico del 12 de Octubre demuestra un tratamiento que reduce la mortalidad por neumonía en lactantes con VIH
14.07.2025 15:36 — 👍 3 🔁 1 💬 0 📌 0
The results of our project #EMPIRICAL speak for themselves - and now the #WHO is set to evaluate them ⚕️
A groundbreaking treatment reducing #pneumonia mortality in #HIV positive #infants 👇
Proud of this milestone and the amazing team behind it 👏
#ECTP3 #postdischarge #CMV #CLHIV
15.07.2025 11:31 — 👍 2 🔁 0 💬 0 📌 0
At #IAS25 important presentation by Alfredo Tagarro on #EARTH cohort viral reservoir results in #children living with #HIV, led by @pentafoundation.bsky.social and #EPIICAL 📊
@iasociety.bsky.social #CLHIV #pediatrics
14.07.2025 08:42 — 👍 4 🔁 1 💬 0 📌 1
Great presentation by @cintamoraleda.bsky.social from #GlobalPID and @pentafoundation.bsky.social 👏
14.07.2025 08:33 — 👍 4 🔁 1 💬 0 📌 1
At the International Workshop on #Pediatrics & HIV: #EMPIRICAL presented the results of the minimally invasive autopsies in infants living with #HIV and #pneumonia: over 50% of the cases deaths were caused by P. jirovecci and CMV coinfection!
14.07.2025 08:32 — 👍 2 🔁 1 💬 1 📌 0
It is a very important meeting, we will present results from the #EMPIRICAL Trial, @pentafoundation.bsky.social SHIELD trial and #EPIICAL results!
11.07.2025 08:09 — 👍 3 🔁 1 💬 0 📌 0
The 17th International Workshop on Pediatrics & HIV starts today in Rwanda to discuss and learn about #PediatricsHIV 🚼
The #EMPIRICAL team will present important results related to treatment of pneumonia in infants living with #HIV 🏥
See you there! @academicmededu.bsky.social
11.07.2025 08:05 — 👍 3 🔁 1 💬 1 📌 1
IAS 2025 location | IAS 2025
The location of IAS 2025 will allow for a much-needed focus on challenges and opportunities in some of the world’s most HIV-affected regions, including the region hosting the conference.
🌍 #IAS2025 takes place in less than 1 week in #Kigali, #Rwanda and virtually!
The location will shine a spotlight on the challenges and opportunities in some of the world’s most #HIV-affected regions.
☑️ Learn more and join us!
07.07.2025 07:53 — 👍 2 🔁 1 💬 0 📌 0
Please join us for a satellite session co-hosted by Unitaid and CHAI at IAS 2025
Please join us for a satellite session co-hosted by Unitaid and CHAI at IAS 2025
📆 Next Monday 14th of July join us in Kigali for the #THRIVE satellite at #IAS: Lives in the balance⚕️
The session will focus on #AHD programs to maintain continuity of care amid shifting financial landscapes 🩺
@pentafoundation.bsky.social @iasociety.bsky.social
www.thriveinfo.org/post/please-...
07.07.2025 10:24 — 👍 3 🔁 3 💬 0 📌 0
Advanced HIV Disease in Children - Generating Evidence to Address an Urgent Challenge through the THRIVE Project
Penta is conducting critical assessments to address gaps by generating operational evidence across three countries.
📚Recommended read on the current situation of advanced #HIV disease in children👶
#THRIVE project is enabling access to prevention, screening and treatment, centering local leadership and community-owned solutions to serve people living with #AHD where they are⚕️
www.thriveinfo.org/post/advance...
24.06.2025 10:44 — 👍 3 🔁 2 💬 0 📌 1
#Lenacapavir’s #FDA approval is a major step forward for #HIV prevention. We must ensure it’s accessible and affordable globally.
Join IAS President Beatriz Grinsztejn in calling for equitable access to lenacapavir for all communities, especially those most vulnerable!
19.06.2025 08:49 — 👍 25 🔁 13 💬 0 📌 0
The countdown is on! #IAS2025 pre-conferences kick off in exactly 3 weeks!
📰 View the full conference programme: zurl.co/Nz3Fz
👥 Discover featured speakers: zurl.co/vVsez
☑️ Register to join us: zurl.co/HtskV
22.06.2025 12:06 — 👍 7 🔁 3 💬 0 📌 0
Unitaid welcomes U.S. FDA approval of lenacapavir and calls for urgent action on affordability and access - Unitaid
The @fda.gov’s approval of lenacapavir for HIV prevention marks a major step forward. This long-acting injectable could revolutionize protection for people at highest risk. But approval is just the beginning. Now we must ensure access.
Learn more: unitaid.org/news-blog/un...
18.06.2025 20:10 — 👍 5 🔁 3 💬 0 📌 1
👏 Exciting moment at #EDCTPForum as our colleague Damalie (Makerere University) presents her oral communication on:
🧠 Neurocognitive function among infants living with #HIV with and without severe pneumonia in Uganda
This important work is part of our #EMPIRICAL project #GlobalHealth #EDCTP3
18.06.2025 08:29 — 👍 2 🔁 1 💬 0 📌 0
Proud to see our #SUPPORT training underway — empowering young African researchers to lead ethical and impactful studies on child health and #HIV 🌍🧑⚕️ #GlobalHealth #ResearchLeadership #EDCTP3
18.06.2025 07:51 — 👍 1 🔁 1 💬 0 📌 0
TikTok - Make Your Day
vm.tiktok.com/ZMSPuPLXq/ #EDCTPForum Kigali Day 1. An inspiring and uplifting celebration of partnership, achievement, innovation, progress and increasing equity in clinical trials partnership. @EDCTP3 @VirTUAL_UoL @IDIMakerere #AtTheEquatorUG
16.06.2025 05:56 — 👍 1 🔁 1 💬 0 📌 0
At conferences, I find the poster presentations by young scientists more captivating than the keynote speeches. The #EDCTPForum showcased a wealth of enthusiasm for empowering young African scientists to progress in their field. #Global #Health #Science #Capacity #Africa
17.06.2025 11:41 — 👍 15 🔁 2 💬 0 📌 0
👀 Now at #EDCTPForum, our colleage Vivian from #UZCRC is currently presenting her poster on "Pharmacokinetics and pharmacodynamics of ganciclovir in infants living with #HIV receiving #valganciclovir for #EMPIRICAL treatment of #CMV pneumonia in sub-Saharan Africa"
⬇️ Check out her results!
17.06.2025 11:47 — 👍 0 🔁 0 💬 0 📌 0
🔍 Very engaging session at #EDCTPForum on the vital role of training the next generation of African researchers 🧑🏫
Happy to see this align with our #SUPPORT project, focused on capacity building and career development for 13 African fellows 🌍💡
17.06.2025 11:27 — 👍 2 🔁 1 💬 0 📌 0
YouTube video by Global-PID
Presentation of EMPIRICAL project
👇Check out our new video for #EMPIRICAL project!
EMPIRICAL aims to develop a #clinicaltrial to evaluate whether empirical treatment against #cytomegalovirus and #tuberculosis improves survival of #HIV infected infants with severe #pneumonia 👶🏥
📽️ youtu.be/kynFk2gVQfs
11.06.2025 07:30 — 👍 1 🔁 0 💬 0 📌 0
Venue information | IAS 2025
IAS 2025, the 13th IAS Conference on HIV Science will take place at the Kigali Convention Centre
🌟 #IAS2025 will take place at the Kigali Convention Centre, and virtually, from 13-17 July!
Learn about this state-of-the-art venue in #Kigali, #Rwanda that will host the 13th IAS Conference on #HIV Science!
08.06.2025 14:15 — 👍 3 🔁 1 💬 0 📌 1
Welcome to the official Bluesky account for the New England Journal of Medicine!
Follow us for high-quality, peer-reviewed research and clinical content from the world’s leading medical journal and website (NEJM.org).
Scientific & medical education programs for healthcare professionals. 🔬
#HIV #Hepatitis #Tuberculosis #LiverDisease #LongCOVID #MedSky #IDSky #PedSky #STISky #LiverSky #UequalsU #HIVEndStigma
🔗 Website: https://academicmedicaleducation.com
The Pediatric Infectious Disease Journal® (PIDJ) is a complete, up-to-the-minute resource on #infectious #diseases in #children.COVID19:
https://journals.lww.com/pidj/pages/collectiondetails.aspx?TopicalCollectionId=19
Developing leaders and accelerating solutions to the world’s most pressing challenges.
The Malaria and Neglected Tropical Diseases Research Capacity Development (MARCAD Plus) in West and Central Africa is a programme that supports Masters, PhD and Postdoctoral fellows by strengthening their capacities in malaria & NTDs ’s researches.
JAMA Health Forum is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications.
🌐 JAMAHealthForum.com
Nature Portfolio’s high-quality products and services across the life, physical, chemical and applied sciences is dedicated to serving the scientific community.
Saving the world, one prevented infection at a time.
PedsID, IPC, A little bit of this, a little bit of that
Compte officiel. Université Paris Cité, Illuminons le monde de demain. #EnlightenTheFuture #IlluminonsLeMondeDeDemain ✨
News and expert comment from the London School of Hygiene & Tropical Medicine (LSHTM). Celebrating 125 years as one of the world's leading #PublicHealth universities. https://linktr.ee/lshtm
- Prevention and management tools for reducing antibiotic resistance in high prevalence settings.
-An EU #H2020 project.
www.reverseproject.eu
#AMR #InfectionPrevention #Microbiology #AntibioticStewardship #Research #ScienceLeadership #ImpSci #Innovation
The Penta Foundation is a global leader in paediatric infectious disease research. We're committed to developing innovative solutions to protect the health of children and pregnant people worldwide.
💻 https://penta-id.org/
Catalysing action on gender and equity in antimicrobial resistance. Working with Fleming Fund country grantees
https://gearupaction.org/
#BIOSECURE project aims to provide enhanced and cost-effective biosecurity in livestock production
www.biosecure.eu
A unique and international medical journal for respiratory and critical care specialists.
🌐 https://www.thelancet.com/journals/lanres/home
EU regulatory authority working for public and animal health.
We ensure that all medicines available on the EU market are high quality, safe and effective. Based in Amsterdam.
https://www.ema.europa.eu/
La mayor universidad presencial de España, con la mejor oferta educativa. En Madrid, rodeada de zonas verdes y con una intensa vida cultural y deportiva.
Cuenta oficial del Consorcio Centro de Investigación Biomédica en Red, CIBER del Instituto de Salud Carlos III. Nuestro objetivo es impulsar la investigación en Biomedicina y Ciencias de la Salud.
Web: https://www.ciberisciii.es/